CB2 Insights Launches Industry’s First Medical Cannabis Insights Dashboard for All Medical Cannabis Stakeholders

NEXT STORY
NextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of Directors
PREV STORY
Revive Therapeutics Provides Corporate Update on its COVID-19 and Infectious Diseases Programs
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Diffusion Pharmaceuticals Chief Scientific Officer Dr. John L. Gainer to Present at 2018 Annual Meeting of the Society for NeuroOncology

Poster Presentation to Focus on Phase 3 GBM Brain Cancer Clinical Trial; 40 Percent ...

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals Achieves Target Enrollment of 500 Patients in Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 ®️ (devimistat) for Patients with Metastatic Pancreatic Cancer

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimistat) in Combination with Hydroxychloroquine for Patients with Clear Cell Sarcoma of Soft

author_avatar
NASDAQ Market News